The Pennant Group, Inc. (NASDAQ:PNTG – Get Free Report) Director Joanne Stringfield sold 380 shares of the business’s stock in a transaction dated Wednesday, October 23rd. The shares were sold at an average price of $33.56, for a total transaction of $12,752.80. Following the completion of the sale, the director now directly owns 27,805 shares of the company’s stock, valued at $933,135.80. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
The Pennant Group Price Performance
PNTG stock opened at $33.53 on Friday. The Pennant Group, Inc. has a 52-week low of $10.46 and a 52-week high of $37.13. The business has a 50-day simple moving average of $33.94 and a two-hundred day simple moving average of $27.58. The company has a market capitalization of $1.01 billion, a P/E ratio of 62.09, a price-to-earnings-growth ratio of 3.42 and a beta of 2.01. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.12 and a current ratio of 1.12.
The Pennant Group (NASDAQ:PNTG – Get Free Report) last issued its earnings results on Tuesday, August 6th. The company reported $0.19 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.02. The Pennant Group had a net margin of 3.16% and a return on equity of 13.74%. The business had revenue of $168.75 million for the quarter, compared to analysts’ expectations of $156.71 million. Research analysts expect that The Pennant Group, Inc. will post 0.75 EPS for the current fiscal year.
Hedge Funds Weigh In On The Pennant Group
Wall Street Analysts Forecast Growth
A number of equities research analysts have issued reports on PNTG shares. Oppenheimer increased their price objective on shares of The Pennant Group from $28.00 to $34.00 and gave the stock an “outperform” rating in a research note on Thursday, August 8th. Stephens restated an “overweight” rating and set a $40.00 price objective on shares of The Pennant Group in a research report on Wednesday, October 9th. Truist Financial raised their price target on shares of The Pennant Group from $34.00 to $38.00 and gave the company a “hold” rating in a research note on Monday, October 7th. Finally, Royal Bank of Canada upped their price target on shares of The Pennant Group from $26.00 to $38.00 and gave the stock an “outperform” rating in a report on Wednesday.
Check Out Our Latest Stock Analysis on The Pennant Group
About The Pennant Group
The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.
Featured Articles
- Five stocks we like better than The Pennant Group
- Comparing and Trading High PE Ratio Stocks
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- What is the S&P 500 and How It is Distinct from Other Indexes
- MarketBeat Week in Review – 10/21- 10/25
- What Are the U.K. Market Holidays? How to Invest and Trade
- Texas Roadhouse Stock Steering for New Highs This Year
Receive News & Ratings for The Pennant Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Pennant Group and related companies with MarketBeat.com's FREE daily email newsletter.